Catalog Number FVL12060 |
Device Problems
Positioning Failure (1158); Fracture (1260); Activation Failure (3270)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/07/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that during a stent graft placement procedure in the common iliac artery, during the release process, the stent allegedly had no response and could not be released.The procedure was completed by using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft are identified in d2 and g4.H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.However, photos were provided for review.The investigation of the reported event is currently underway.H10: d4 (expiry date: 09/2024).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
|
|
Event Description
|
It was reported that during a stent graft placement procedure in the common iliac artery, during the release process, the stent allegedly had no response and could not be released.The procedure was completed by using another device.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: the catalog number identified in section d4 has not been cleared in the us but is similar to the fluency plus endovascular stent graft that are cleared in the us.The pro code and 510 k number for the fluency plus endovascular stent graft are identified in d2 and g4.H10: manufacturing review: the lot history records of this lot were reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met the specification prior to shipment.Based on the information available it is not reasonably suggested that a manufacturing process may have caused or contributed to the reported issue.Investigation summary: the sample was not returned for evaluation but photos were provided which show the outer sheath which is fractured which probably resulted to subsequent deployment failure of the stent graft leading to confirmed results.It was reported that a 10f introducer/0.035" guidewire were used for access, the tracking vessel was neither tortuous nor calcified, the device was flushed prior to use and pre-dilatation was not performed.Based on the provided information and the provided photos, the investigation is closed with confirmed results for failure to deploy and sheath fracture.A definite root cause for the reported event could not be determined.The intended use of this device to treat an abdominal aortic aneurysm represents an off-label use.Labeling review: in reviewing the relevant labeling, it was found that the instructions for use sufficiently address the potential risks.The instructions for use state: "if unusual resistance is met during delivery system introduction, the delivery system should be withdrawn and another delivery system should be used".Regarding preparation of the device the instructions for use state that "prior to loading the vascular system over a guide wire, both ports must be flushed with sterile saline.Flushing these lumens will also facilitate stent graft deployment".Regarding accessories the instructions for use states: "prepare a stiff 0.035" guidewire per its instructions for use and advance the guidewire under fluoroscopy to the target location.The use of an appropriately sized introducer sheath is recommended".The packaging pictograms indicate an introducer size of 9f and a 0.035" guidewire.The instructions for use states "pre-dilatation of the stenotic lesion may be performed prior to stent graft deployment at the discretion of the treating physician".The instructions for use states, "the safety and effectiveness of the device when placed across an aneurysm or a pseudoaneurysm has not been evaluated".H10: d4 (expiration date: 09/2024).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|